{"id":45136,"date":"2025-05-11T21:19:18","date_gmt":"2025-05-11T18:19:18","guid":{"rendered":"https:\/\/entarabi.com\/?p=45136"},"modified":"2025-05-11T21:34:37","modified_gmt":"2025-05-11T18:34:37","slug":"uae-based-metabolic-health-company-endocare-closes-funding-round-to-expand-across-the-middle-east","status":"publish","type":"post","link":"https:\/\/entarabi.com\/en\/2025\/05\/uae-based-metabolic-health-company-endocare-closes-funding-round-to-expand-across-the-middle-east\/","title":{"rendered":"UAE-Based Metabolic Health Company Endocare Closes Funding Round to Expand Across the Middle East"},"content":{"rendered":"<ul>\n<li dir=\"ltr\" style=\"text-align: left;\" data-start=\"275\" data-end=\"361\">Endocare secures strategic funding to support expansion in the UAE and Saudi Arabia.<\/li>\n<li dir=\"ltr\" style=\"text-align: left;\" data-start=\"275\" data-end=\"361\">The company focuses on evidence-based, personalized care for obesity and metabolic health.<\/li>\n<li dir=\"ltr\" style=\"text-align: left;\" data-start=\"275\" data-end=\"361\">RbetaQ Holding, a German family office, led the investment round.<\/li>\n<\/ul>\n<p dir=\"ltr\" style=\"text-align: left;\" data-start=\"526\" data-end=\"832\"><strong data-start=\"526\" data-end=\"542\">Dubai, UAE \u2013<\/strong> Endocare, a UAE-based metabolic health company, has announced the successful closing of a new funding round aimed at expanding its reach across the Middle East. The company is on a mission to enhance health outcomes through a <strong data-start=\"769\" data-end=\"831\">combination of innovative treatments and personalized care<\/strong>.<\/p>\n<p dir=\"ltr\" style=\"text-align: left;\" data-start=\"834\" data-end=\"1019\">This milestone supports Endocare\u2019s efforts to <strong data-start=\"880\" data-end=\"900\">scale operations<\/strong> and further its goal of delivering <strong data-start=\"936\" data-end=\"985\">advanced, science-driven healthcare solutions<\/strong> to individuals across the region.<\/p>\n<h2 dir=\"ltr\" style=\"text-align: left;\" data-start=\"1021\" data-end=\"1066\"><span style=\"font-size: 14pt;\">Strategic Investment to Accelerate Growth<\/span><\/h2>\n<p dir=\"ltr\" style=\"text-align: left;\" data-start=\"1068\" data-end=\"1423\">The round was <strong data-start=\"1082\" data-end=\"1107\">led by RbetaQ Holding<\/strong>, a Germany-based family office with a strong track record of investing in innovative healthcare and technology ventures. The capital will help Endocare execute its ambitious growth plans in key markets, <strong data-start=\"1311\" data-end=\"1349\">including the UAE and Saudi Arabia<\/strong>, where demand for effective metabolic health solutions is rising rapidly.<\/p>\n<p dir=\"ltr\" style=\"text-align: left;\" data-start=\"1425\" data-end=\"1647\">Endocare is particularly focused on addressing the <strong data-start=\"1476\" data-end=\"1553\">growing demand for sustainable, personalized weight loss and obesity care <\/strong>especially in Dubai, where rising health awareness has created a need for targeted solutions.<\/p>\n<h2 dir=\"ltr\" style=\"text-align: left;\" data-start=\"1649\" data-end=\"1675\"><span style=\"font-size: 14pt;\">Leadership Enhancement<\/span><\/h2>\n<p dir=\"ltr\" style=\"text-align: left;\" data-start=\"1677\" data-end=\"1920\">Endocare also announced the appointment of <strong data-start=\"1720\" data-end=\"1738\">Dr. Ashok Kaul<\/strong> to its board of directors. With extensive experience in <strong data-start=\"1795\" data-end=\"1852\">data science, technology, and artificial intelligence<\/strong>, Dr. Kaul will bring valuable insights to the company as it scales.<\/p>\n<blockquote dir=\"ltr\" data-start=\"1922\" data-end=\"2113\">\n<p data-start=\"1924\" data-end=\"2113\"><em data-start=\"1924\" data-end=\"2093\">\u201cDr. Kaul\u2019s expertise will be critical in guiding Endocare through its next growth phase, particularly as we develop and implement scalable patient care technologies,\u201d<\/em> the company stated.<\/p>\n<\/blockquote>\n<h2 dir=\"ltr\" style=\"text-align: left;\" data-start=\"2115\" data-end=\"2133\"><span style=\"font-size: 14pt;\">About Endocare<\/span><\/h2>\n<p dir=\"ltr\" style=\"text-align: left;\" data-start=\"2135\" data-end=\"2358\">Endocare was founded by <strong data-start=\"2159\" data-end=\"2176\">Leyla Azizova<\/strong>, <strong data-start=\"2178\" data-end=\"2199\">Janik Schmalhorst<\/strong>, and <strong data-start=\"2205\" data-end=\"2224\">Dr. Hisham Harb<\/strong>. Based in <strong data-start=\"2235\" data-end=\"2244\">Dubai<\/strong>, the clinic is a leading provider of <strong data-start=\"2282\" data-end=\"2347\">scientifically backed metabolic health and obesity management<\/strong> solutions.<\/p>\n<p dir=\"ltr\" style=\"text-align: left;\" data-start=\"2360\" data-end=\"2421\">The clinic offers an <strong data-start=\"2381\" data-end=\"2406\">integrated care model<\/strong> that combines:<\/p>\n<ul dir=\"ltr\" style=\"text-align: left;\" data-start=\"2422\" data-end=\"2576\">\n<li data-start=\"2422\" data-end=\"2454\">\n<p data-start=\"2424\" data-end=\"2454\"><strong data-start=\"2424\" data-end=\"2452\">Medical hormonal therapy<\/strong><\/p>\n<\/li>\n<li data-start=\"2455\" data-end=\"2576\">\n<p data-start=\"2457\" data-end=\"2576\"><strong data-start=\"2457\" data-end=\"2497\">Personalized lifestyle interventions<\/strong> including nutrition, physical activity, sleep management, and stress reduction<\/p>\n<\/li>\n<\/ul>\n<p dir=\"ltr\" style=\"text-align: left;\" data-start=\"2578\" data-end=\"2740\">This holistic approach is designed to <strong data-start=\"2616\" data-end=\"2651\">support sustainable weight loss<\/strong> and <strong data-start=\"2656\" data-end=\"2683\">extend healthy lifespan<\/strong> through long-term behavioral change and medical support.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Endocare secures strategic funding to support expansion in the UAE and Saudi Arabia. The company focuses on evidence-based, personalized care for obesity and metabolic health. RbetaQ Holding, a German family office, led the investment round. Dubai, UAE \u2013 Endocare, a UAE-based metabolic health company, has announced the successful closing of a new funding round aimed [&hellip;]<\/p>\n","protected":false},"author":37,"featured_media":45133,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"post_subtitle":"","footnotes":""},"categories":[1810],"tags":[8240,8241],"class_list":["post-45136","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fintech","tag-endocare-en","tag-rbetaq-holding-en"],"_links":{"self":[{"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/posts\/45136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/users\/37"}],"replies":[{"embeddable":true,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/comments?post=45136"}],"version-history":[{"count":0,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/posts\/45136\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/media\/45133"}],"wp:attachment":[{"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/media?parent=45136"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/categories?post=45136"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/entarabi.com\/en\/wp-json\/wp\/v2\/tags?post=45136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}